https://oncoguide.xyz/en/ Recent content on OncoGuide Hugo en Tue, 01 Sep 2026 00:00:00 +0000 https://oncoguide.xyz/en/imaging/imaging-equipment-guide/ Mon, 08 Jun 2026 00:00:00 +0000 https://oncoguide.xyz/en/imaging/imaging-equipment-guide/ Not all PET-CT, CT and MRI scanners are equal. If you need scans every few months, the machine quietly decides how much radiation you absorb and how early your cancer is caught. A patient's guide to the best scanners in Romania, Europe and Turkey — ranked by what matters to you. https://oncoguide.xyz/en/cancer-types/lung-ret-fusion/ Thu, 19 Mar 2026 00:00:00 +0000 https://oncoguide.xyz/en/cancer-types/lung-ret-fusion/ Everything you need to know about RET fusion-positive lung cancer: Selpercatinib treatment, side effects, emergencies, resistance, and access options. https://oncoguide.xyz/en/diagnosis/complete-diagnosis-guide/ Sat, 14 Mar 2026 00:00:00 +0000 https://oncoguide.xyz/en/diagnosis/complete-diagnosis-guide/ From suspicion to a complete cancer diagnosis: the right steps, in the right order, with real timelines and AI tools to help patients navigate. https://oncoguide.xyz/en/diagnosis/preserving-tumor-tissue/ Mon, 22 Jun 2026 00:00:00 +0000 https://oncoguide.xyz/en/diagnosis/preserving-tumor-tissue/ How to preserve your tumor tissue for future molecular testing, drug-response work, and personalized therapies. What to ask before a biopsy or surgery. https://oncoguide.xyz/en/cancer-types/lung-ret-fusion-proactive-strategy/ Tue, 14 Apr 2026 00:00:00 +0000 https://oncoguide.xyz/en/cancer-types/lung-ret-fusion-proactive-strategy/ Vaccines, cryoablation, ctDNA, drug repurposing, next-gen RET inhibitors, and the path to NED -- a comprehensive guide for patients and physicians who want more than 'wait and see'. https://oncoguide.xyz/en/blog/my-story/ Mon, 22 Jun 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/my-story/ The real story of a 42-year-old non-smoker diagnosed with RET-positive lung cancer at stage IV. How I went from back pain to a full diagnosis and treatment in ten days. https://oncoguide.xyz/en/treatment/denosumab/ Thu, 11 Jun 2026 00:00:00 +0000 https://oncoguide.xyz/en/treatment/denosumab/ A plain-language guide to denosumab (Xgeva) for bone metastases: the blood tests before every dose, the shift to every 3 months, who carries the rebound risk, how to monitor it through blood, and why you never stop it alone. https://oncoguide.xyz/en/blog/standard-of-care-vs-personalized-medicine/ Fri, 26 Jun 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/standard-of-care-vs-personalized-medicine/ Five months after diagnosis, with a good response to treatment, I'm trying to understand the difference between standard of care and personalized medicine in advanced cancer. https://oncoguide.xyz/en/blog/pet-ct-at-month-6/ Wed, 22 Jul 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/pet-ct-at-month-6/ Six-month follow-up results: stable tumour, nodes still slightly active, a sub-threshold metabolic rise, and the decision to do SBRT on the main tumour. https://oncoguide.xyz/en/blog/personalized-cancer-vaccines/ Wed, 22 Jul 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/personalized-cancer-vaccines/ The types of therapeutic vaccine, what worked and what did not in trials, the real limits, and the centres I found -- plus how I decide what fits me. https://oncoguide.xyz/en/blog/personalized-cancer-vaccines-tissue/ Thu, 23 Jul 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/personalized-cancer-vaccines-tissue/ A personalized cancer vaccine can need far more tumour tissue than a routine test — often fresh-frozen — and a good response to treatment can leave you with no way to get more. What I wish I had secured at the very first biopsy. https://oncoguide.xyz/en/blog/observations-from-the-grey-zone/ Tue, 01 Sep 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/observations-from-the-grey-zone/ Six observations I've collected as a patient -- about surgery and dormant cells, biopsies, treatment injected directly into the tumor, and what's worth doing before starting treatment. Anecdotal, but with sources. https://oncoguide.xyz/en/blog/minimal-residual-disease/ Tue, 01 Sep 2026 00:00:00 +0000 https://oncoguide.xyz/en/blog/minimal-residual-disease/ Why the total amount of tumor in your body is a strategic variable: three mechanisms, the lesson from leukemias, the trials backing early aggressive local consolidation -- and where the caution of standard of care gets it right. https://oncoguide.xyz/en/registry/ret-patient-registry/ Tue, 01 Sep 2026 00:00:00 +0000 https://oncoguide.xyz/en/registry/ret-patient-registry/ The medical data of RET+ patients sits fragmented in institutional registries patients cannot access. Other cancer communities built their own registries and changed research. We propose the same -- and we are asking for your opinion. https://oncoguide.xyz/en/about/ Mon, 01 Jan 0001 00:00:00 +0000 https://oncoguide.xyz/en/about/ Who we are, why we exist, and how you can contribute to OncoGuide. https://oncoguide.xyz/en/contact/ Mon, 01 Jan 0001 00:00:00 +0000 https://oncoguide.xyz/en/contact/ Reach out with questions, suggestions, or to collaborate https://oncoguide.xyz/en/donor-privacy/ Mon, 01 Jan 0001 00:00:00 +0000 https://oncoguide.xyz/en/donor-privacy/ How your data is protected when you support OncoGuide: browser-only processing, nothing stored on servers, copies shared only with your explicit consent. https://oncoguide.xyz/en/donate/persoane-fizice/ Mon, 01 Jan 0001 00:00:00 +0000 https://oncoguide.xyz/en/donate/persoane-fizice/ Romanian employees can redirect 3.5% of their already-paid income tax to OncoGuide via Form 230, at zero personal cost. Guide on the Romanian page. https://oncoguide.xyz/en/donate/firme/ Mon, 01 Jan 0001 00:00:00 +0000 https://oncoguide.xyz/en/donate/firme/ Romanian companies paying profit tax can redirect up to 20% of it to OncoGuide via a sponsorship contract. Step-by-step guide on the Romanian page.